Market Closed -
Nyse
21:00:02 17/05/2024 BST
5-day change
1st Jan Change
147.7
USD
+0.09%
-0.55%
+19.45%
Presentation Operator MessageOperator (Operator)Ladies and gentlemen, thank you for standing b...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Aptargroup Insider Sold Shares Worth $672,344, According to a Recent SEC Filing
05-01
MT
North American Morning Briefing : More Earnings -2-
04-30
DJ
Baird Adjusts Price Target on AptarGroup to $170 From $150, Maintains Outperform Rating
04-29
MT
William Blair Upgrades AptarGroup to Outperform From Market Perform
04-29
MT
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
04-26
CI
Transcript : AptarGroup, Inc., Q1 2024 Earnings Call, Apr 26, 2024
04-26
AptarGroup Q1 Adjusted Earnings, Sales Rise; Sets Q2 EPS Guidance
04-25
MT
Aptargroup, Inc. Provides Earnings Guidance for the Second Quarter of 2024
04-25
CI
Aptargroup, Inc. Approves Quarterly Dividend, Payable on May 16, 2024
04-25
CI
AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
04-25
CI
Earnings Flash (ATR) APTARGROUP Posts Q1 Revenue $915.4M, vs. Street Est of $890.9M
04-25
MT
Earnings Flash (ATR) APTARGROUP Reports Q1 EPS $1.26, vs. Street Est of $1.15
04-25
MT
AptarGroup Keeps Quarterly Cash Dividend at $0.41 a Share, Payable May 16 to Holders of Record April 25
04-11
MT
AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024
04-11
CI
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing
03-12
MT
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing
03-12
MT
Wells Fargo Adjusts AptarGroup's Price Target to $160 From $157, Maintains Overweight Rating
03-07
MT
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing
03-05
MT
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector
02-12
MT
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases
02-09
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
02-09
MT
Transcript : AptarGroup, Inc., Q4 2023 Earnings Call, Feb 09, 2024
02-09
AptarGroup Q4 Adjusted Earnings, Sales Rise; Sets Q1 Outlook
02-08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 Revenue $838.5M, vs. Street Est of $842.5M
02-08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 EPS $1.21, vs. Street Est of $1.12
02-08
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
More about the company
Last Close Price
147.7
USD
Average target price
159
USD
Spread / Average Target
+7.67%
Consensus
1st Jan change
Capi.
+19.45% 9.79B +6.54% 14.83B -9.96% 6.94B +17.06% 1.48B +28.40% 1.43B -10.32% 1.38B +29.15% 1.27B -21.51% 1.05B +21.68% 862M +62.11% 780M
Plastic Containers & Packaging
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1